Treatment for Parkinsonism, other than levodopa.
D000547:Amantadine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010276:Parasympatholytics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000601:surgery; D010302:Parkinson Disease, Secondary / Q000139:chemically induced
D010276:Parasympatholytics; D000547:Amantadine